Adamas Pharmaceuticals, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$2.3Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
3,685clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.0M
2020 $573K
2021 $706K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Neurology (Psychiatry & Neurology) $2.1M
Psychiatry $64K
Family $8,562
Internal Medicine $8,380
Physician Assistant $6,356
Nurse Practitioner $5,608

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Cherian Karunapuzha Oklahoma City, OK Neurology (Psychiatry & Neurology) $153,885.83
Stuart Isaacson Boca Raton, FL Neurology (Psychiatry & Neurology) $116,278.07
Paula Ravin Los Angeles, CA Neurology (Psychiatry & Neurology) $96,050.15
Michelle Dagostine Cheshire, CT Neurology (Psychiatry & Neurology) $93,268.15
Nirav Pavasia Dallas, TX Neurology (Psychiatry & Neurology) $90,146.75
Khashayar Dashtipour Loma Linda, CA Neurology (Psychiatry & Neurology) $82,891.07
Bruno Gallo Miami, FL Neurology (Psychiatry & Neurology) $82,023.28
Robert Fekete Hawthorne, NY Neurology (Psychiatry & Neurology) $76,771.26
Duarte Machado Cheshire, CT Neurology (Psychiatry & Neurology) $71,891.25
Pinky Agarwal Kirkland, WA Neurology (Psychiatry & Neurology) $67,452.91

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.